Phase 3 randomized, open-label study to evaluate Eflornithine with Lomustine compared to Lomustine (STELLAR) alone in patients with Anaplastic Astrocytoma
Clinical Trial Grant
Awarded By
Orbus Therapeutics, Inc.
Start Date
October 1, 2016
End Date
July 15, 2023
Awarded By
Orbus Therapeutics, Inc.
Start Date
October 1, 2016
End Date
July 15, 2023